Key points are not available for this paper at this time.
Vericiguat has been used to treat patients with heart failure with reduced ejection fraction (HFrEF) who demonstrated worsening heart failure despite treatment with other guideline-directed medical therapies. The haemodynamic effects of vericiguat remain unclear.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hideaki Suzuki
New Mexico State University
Takumi Inoue
Interventional / Structural Cardiology
Yousuke Terui
Tohoku University
ESC Heart Failure
Imperial College London
Tohoku University
National Cerebral and Cardiovascular Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Suzuki et al. (Mon,) studied this question.
synapsesocial.com/papers/68e6d04db6db64358764dbdb — DOI: https://doi.org/10.1002/ehf2.14802